Literature DB >> 17245123

Oct-3/4: not just a gatekeeper of pluripotency for embryonic stem cell, a cell fate instructor through a gene dosage effect.

Sonia Stefanovic1, Michel Pucéat.   

Abstract

Oct-3/4 encoded by Pou5f1 has been longwise recognised as a gatekeeper for embryonic stem (ES) cell pluripotency. Recently, it was suggested that Oct-3/4 one of the earliest transcription factor of the embryo might feature some functions in differentiation of cell lineages. We recently uncovered a key role of Oct-3/4 in both ES cell specification toward a cardiac lineage and in mesodermal commitment of the embryonic epiblast. Our findings demonstrated a gene dosage effect of Oct-3/4, a factor at the cross-road between cell self-renewal and cell lineage specification. What is the genetic and/or epigenetic mechanism underlying this process is still questionable. The extraview presents some hypotheses that might account for the pleiotropic dose-dependent functions of Oct-3/4.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245123     DOI: 10.4161/cc.6.1.3633

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  14 in total

1.  Tbx6 is a determinant of cardiac and neural cell fate decisions in multipotent P19CL6 cells.

Authors:  Svetlana Gavrilov; Thomas G Nührenberg; Anthony W Ashton; Chang-Fu Peng; Jennifer C Moore; Klitos Konstantinidis; Christine L Mummery; Richard N Kitsis
Journal:  Differentiation       Date:  2012-06-19       Impact factor: 3.880

2.  A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates.

Authors:  Guillaume Blin; David Nury; Sonia Stefanovic; Tui Neri; Oriane Guillevic; Benjamin Brinon; Valérie Bellamy; Catherine Rücker-Martin; Pascal Barbry; Alain Bel; Patrick Bruneval; Chad Cowan; Julia Pouly; Shoukhrat Mitalipov; Elodie Gouadon; Patrice Binder; Albert Hagège; Michel Desnos; Jean-François Renaud; Philippe Menasché; Michel Pucéat
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

Review 3.  Transcription factors and neural stem cell self-renewal, growth and differentiation.

Authors:  Sohail Ahmed; Hui Theng Gan; Chen Sok Lam; Anuradha Poonepalli; Srinivas Ramasamy; Yvonne Tay; Muly Tham; Yuan Hong Yu
Journal:  Cell Adh Migr       Date:  2009-10-27       Impact factor: 3.405

4.  Novel AKT phosphorylation sites identified in the pluripotency factors OCT4, SOX2 and KLF4.

Authors:  Peter N Malak; Benjamin Dannenmann; Alexander Hirth; Oliver C Rothfuss; Klaus Schulze-Osthoff
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 5.  The Oct4 protein: more than a magic stemness marker.

Authors:  Dana Zeineddine; Aya Abou Hammoud; Mohamad Mortada; Hélène Boeuf
Journal:  Am J Stem Cells       Date:  2014-09-05

6.  WWP2 ubiquitin ligase and its isoforms: new biological insight and promising disease targets.

Authors:  Andrew Chantry
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

7.  A novel and critical role for Oct4 as a regulator of the maternal-embryonic transition.

Authors:  Kira Foygel; Bokyung Choi; Sunny Jun; Denise E Leong; Alan Lee; Connie C Wong; Elizabeth Zuo; Michael Eckart; Renee A Reijo Pera; Wing H Wong; Mylene W M Yao
Journal:  PLoS One       Date:  2008-12-31       Impact factor: 3.240

Review 8.  Potential of Induced Pluripotent Stem Cells for Use in Gene Therapy: History, Molecular Bases, and Medical Perspectives.

Authors:  Agnieszka Fus-Kujawa; Barbara Mendrek; Anna Trybus; Karolina Bajdak-Rusinek; Karolina L Stepien; Aleksander L Sieron
Journal:  Biomolecules       Date:  2021-05-07

Review 9.  Very small embryonic-like stem cells: implications in reproductive biology.

Authors:  Deepa Bhartiya; Sreepoorna Unni; Seema Parte; Sandhya Anand
Journal:  Biomed Res Int       Date:  2013-02-13       Impact factor: 3.411

10.  Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary.

Authors:  Chantel Samardzija; Michael Quinn; Jock K Findlay; Nuzhat Ahmed
Journal:  J Ovarian Res       Date:  2012-11-21       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.